Form 8-K - Current report:
SEC Accession No. 0001628280-25-055939
Filing Date
2025-12-09
Accepted
2025-12-08 21:13:55
Documents
12
Period of Report
2025-12-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K lfvn-20251203.htm   iXBRL 8-K 23551
  Complete submission text file 0001628280-25-055939.txt   141183

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20251203.xsd EX-101.SCH 1807
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20251203_lab.xml EX-101.LAB 22804
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20251203_pre.xml EX-101.PRE 13066
14 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20251203_htm.xml XML 2798
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

EIN.: 900224471 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35647 | Film No.: 251557439
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)